tiprankstipranks
Advertisement
Advertisement

HK:2511 Stock Latest News

HighTide Therapeutics Sets Board Meeting to Approve Interim Results
Company AnnouncementsHighTide Therapeutics Sets Board Meeting to Approve Interim Results
6d ago
2511
HighTide Therapeutics Raises HK$225 Million Through Share Placing to Fund HTD1801 Expansion
PremiumCompany Announcements
HighTide Therapeutics Raises HK$225 Million Through Share Placing to Fund HTD1801 Expansion
13d ago
2511
HighTide Therapeutics Launches Discounted Share Placing to Raise HK$225 Million
PremiumCompany Announcements
HighTide Therapeutics Launches Discounted Share Placing to Raise HK$225 Million
19d ago
2511
HighTide Therapeutics advances HTD1801 commercialization after NEJM Evidence recognition
PremiumCompany Announcements
HighTide Therapeutics advances HTD1801 commercialization after NEJM Evidence recognition
1M ago
2511
HighTide Therapeutics Terminates Connected Loan After Regulatory Scrutiny
PremiumCompany Announcements
HighTide Therapeutics Terminates Connected Loan After Regulatory Scrutiny
2M ago
2511
HighTide Therapeutics Wins Strong Shareholder Backing at 2026 AGM
PremiumCompany AnnouncementsHighTide Therapeutics Wins Strong Shareholder Backing at 2026 AGM
2M ago
2511
HighTide Therapeutics Sets 2026 AGM to Approve Accounts, Board Slate and Share Issuance Mandate
Premium
Company Announcements
HighTide Therapeutics Sets 2026 AGM to Approve Accounts, Board Slate and Share Issuance Mandate
3M ago
2511
HighTide Therapeutics Strengthens Board With Appointment of Veteran Audit Chairman
Premium
Company Announcements
HighTide Therapeutics Strengthens Board With Appointment of Veteran Audit Chairman
4M ago
2511
HighTide Therapeutics Details Board Composition and Committee Roles
PremiumCompany Announcements
HighTide Therapeutics Details Board Composition and Committee Roles
4M ago
2511
HighTide Therapeutics Grants HK$15 Million Connected-Party Loan to Founder-CEO
PremiumCompany Announcements
HighTide Therapeutics Grants HK$15 Million Connected-Party Loan to Founder-CEO
4M ago
2511
HighTide Therapeutics Highlights HTD1801’s Potential as Foundational CKM Therapy in 2025 Results
PremiumCompany Announcements
HighTide Therapeutics Highlights HTD1801’s Potential as Foundational CKM Therapy in 2025 Results
5M ago
2511
HighTide positions HTD1801 as potential foundational therapy for CKM diseases
PremiumCompany Announcements
HighTide positions HTD1801 as potential foundational therapy for CKM diseases
5M ago
2511
HighTide Therapeutics Sets March 27 Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsHighTide Therapeutics Sets March 27 Board Meeting to Approve 2025 Annual Results
5M ago
2511
HighTide’s First NDA for Diabetes Drug HTD1801 Accepted by China’s NMPA
Premium
Company Announcements
HighTide’s First NDA for Diabetes Drug HTD1801 Accepted by China’s NMPA
5M ago
2511
HighTide Flags Trial Quality Issues After Completing Phase IIb MASH Study of HTD1801
Premium
Company Announcements
HighTide Flags Trial Quality Issues After Completing Phase IIb MASH Study of HTD1801
7M ago
2511
HighTide Therapeutics Names Veteran Cardiometabolic Leader Filip Surmont as Chief Medical Officer
PremiumCompany Announcements
HighTide Therapeutics Names Veteran Cardiometabolic Leader Filip Surmont as Chief Medical Officer
7M ago
2511
HighTide Therapeutics Sets Up Nomination Committee to Bolster Governance
PremiumCompany Announcements
HighTide Therapeutics Sets Up Nomination Committee to Bolster Governance
8M ago
2511
HighTide Therapeutics’ HTD1801 Outperforms in Phase III Trial
PremiumCompany Announcements
HighTide Therapeutics’ HTD1801 Outperforms in Phase III Trial
9M ago
2511
HighTide Therapeutics Showcases Renal Benefits of HTD1801 at ASN Meeting
PremiumCompany Announcements
HighTide Therapeutics Showcases Renal Benefits of HTD1801 at ASN Meeting
10M ago
2511
HighTide Therapeutics Reports Positive Phase III Results for HTD1801 in Diabetes Treatment
PremiumCompany AnnouncementsHighTide Therapeutics Reports Positive Phase III Results for HTD1801 in Diabetes Treatment
10M ago
2511
Premium
Company Announcements
HighTide Therapeutics Reports Promising Interim Results for 2025
12M ago
2511
Premium
Company Announcements
HighTide Therapeutics Partners with Chinese Academy for Metabolic Disease Research
1y ago
2511

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >